Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2010 1
2011 2
2013 2
2014 1
2015 4
2016 3
2017 1
2018 1
2020 3
2021 2
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mitsutake yamamoto (21 results)?
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Teerlink JR, et al. N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33185990 Free article. Clinical Trial.
Association of Serum Oxysterols with Cholesterol Metabolism Markers and Clinical Factors in Patients with Coronary Artery Disease: A Covariance Structure Analysis.
Akiyama Y, Katsuki S, Matoba T, Nakano Y, Takase S, Nakashiro S, Yamamoto M, Mukai Y, Inoue S, Oi K, Higo T, Takemoto M, Suematsu N, Eshima K, Miyata K, Usui M, Sadamatsu K, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Tsutsui H. Akiyama Y, et al. Among authors: yamamoto m. Nutrients. 2023 Jun 30;15(13):2997. doi: 10.3390/nu15132997. Nutrients. 2023. PMID: 37447327 Free PMC article.
Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma.
Yamamoto Y, Yatsuda J, Shimokawa M, Fuji N, Aoki A, Sakano S, Yamamoto M, Suga A, Tei Y, Yoshihiro S, Kitahara S, Nagao K, Takai K, Kamiryo Y, Akao J, Yamaguchi S, Oba K, Shimabukuro T, Matsumoto H, Kamba T, Matsuyama H. Yamamoto Y, et al. Among authors: yamamoto m. Int J Clin Oncol. 2021 Jan;26(1):169-177. doi: 10.1007/s10147-020-01784-w. Epub 2020 Sep 18. Int J Clin Oncol. 2021. PMID: 32948925
[Successful treatment with rituximab for type III cryoglobulinemia].
Suehiro Y, Ishido A, Shigeoka T, Tominaga T, Korenaga Y, Yamamoto M, Takahashi T. Suehiro Y, et al. Among authors: yamamoto m. Rinsho Ketsueki. 2015 Feb;56(2):220-4. doi: 10.11406/rinketsu.56.220. Rinsho Ketsueki. 2015. PMID: 25765804 Japanese.
Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan.
Nakano Y, Matoba T, Yamamoto M, Katsuki S, Koga Y, Mukai Y, Inoue S, Suematsu N, Higo T, Takemoto M, Miyata K, Usui M, Kadokami T, Tashiro H, Morishige K, Hironaga K, Tsutsui H; QcVIC Investigators. Nakano Y, et al. Among authors: yamamoto m. Circ Rep. 2023 Jun 6;5(7):282-288. doi: 10.1253/circrep.CR-23-0047. eCollection 2023 Jul 10. Circ Rep. 2023. PMID: 37435100 Free PMC article.
Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial.
Nakano Y, Yamamoto M, Matoba T, Katsuki S, Nakashiro S, Takase S, Akiyama Y, Nagata T, Mukai Y, Inoue S, Oi K, Higo T, Takemoto M, Suematsu N, Eshima K, Miyata K, Usui M, Sadamatsu K, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Tsutsui H. Nakano Y, et al. Among authors: yamamoto m. J Atheroscler Thromb. 2023 Aug 1;30(8):907-918. doi: 10.5551/jat.63507. Epub 2022 Dec 1. J Atheroscler Thromb. 2023. PMID: 36450458 Free PMC article. Clinical Trial.
Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial.
Takase S, Matoba T, Nakashiro S, Mukai Y, Inoue S, Oi K, Higo T, Katsuki S, Takemoto M, Suematsu N, Eshima K, Miyata K, Yamamoto M, Usui M, Sadamatsu K, Satoh S, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Egashira K, Sunagawa K. Takase S, et al. Among authors: yamamoto m. Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):350-358. doi: 10.1161/ATVBAHA.116.308388. Epub 2016 Dec 8. Arterioscler Thromb Vasc Biol. 2017. PMID: 27932353 Clinical Trial.
Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma.
Sakano S, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Kaneda Y, Nasu T, Baba Y, Shimabukuro T, Suga A, Yamamoto M, Aoki A, Takai K, Yoshihiro S, Oba K; Yamaguchi Uro-Oncology Group. Sakano S, et al. Among authors: yamamoto m. Int J Clin Oncol. 2015 Apr;20(2):362-8. doi: 10.1007/s10147-014-0721-3. Epub 2014 Jun 27. Int J Clin Oncol. 2015. PMID: 24964974
19 results